Triangle Biostatistics赞助的临床试验
总计127个结果
-
Enanta Pharmaceuticals, IncPharmaceutical Research Associates; Triangle Biostatistics完全的
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle Biostatistics完全的
-
Bristol-Myers SquibbBoehringer Ingelheim; Triangle Pharmaceuticals终止
-
AbbottGroup Data Management Biostatistics完全的类风湿关节炎 | 银屑病关节炎 | 强直性脊柱炎奥地利
-
Triangle Pharmaceuticals完全的
-
Nantes University HospitalCSAPA Apsyades; OPPELIA-Le triangle完全的
-
Bristol-Myers SquibbTriangle Pharmaceuticals; Pharmacia and Upjohn终止
-
Triangle Pharmaceuticals未知
-
Centers for Disease Control and PreventionChildren's Research Triangle完全的
-
AbbottAssign Data Management and Biostatistics GmbH完全的
-
AbbottAssign Data Management and Biostatistics GmbH完全的
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel Scientific完全的
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel Scientific完全的高脂蛋白血症 | 高同型半胱氨酸血症俄罗斯联邦
-
NHS Greater Glasgow and ClydeRobertson Centre for Biostatistics招聘中
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel Scientific完全的低密度脂蛋白血症 | 低密度脂蛋白型 [LDL] 高脂蛋白血症 | 甘油三酯储存 I 型或 II 型疾病俄罗斯联邦
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel Scientific完全的
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel Scientific完全的
-
AeskuLab Pathology PragueInstitute of Biostatistics and analyses, Ltd.完全的
-
Centre Leon BerardThe Biostatistics and Therapy Evaluation Unit完全的
-
PfizerBiostatistics, Preventive Medicinte Department, College of Medicine, Yonsei University完全的
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgen; Assign Data Management and Biostatistics GmbH主动,不招人
-
Themis Bioscience GmbHAssign Data Management and Biostatistics GmbH; Optimapharm撤销
-
Nova Southeastern UniversitySoutheastern Orthopedics Sports Medicine and Shoulder Center; Triangle Volleyball, Inc.完全的
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbH完全的
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH完全的神经内分泌癌,3 级 | 低分化恶性神经内分泌癌 | 转为 G3 的 1 级神经内分泌癌 [分化良好的神经内分泌癌] | 转为 G3 的 2 级神经内分泌癌 [中度分化神经内分泌癌] | 神经内分泌肿瘤,3 级和疾病进展,根据实体瘤反应评估标准 (RECIST 1.1.) 衡量德国